Innovative approaches in characterizing and developing methods for lipoidal vesicular drug delivery systems
Sr. Analytical Scientist, Flamma USA LLC, Malvern, PA,19355.
Review Article
GSC Advanced Research and Reviews, 2024, 20(01), 427–438.
Article DOI: 10.30574/gscarr.2024.20.1.0278
Publication history:
Received on 16 June 2024; revised on 24 July 2024; accepted on 26 July 2024
Abstract:
Lipoidal vesicular systems, including liposomes, ethosomes, and transferosomes, represent a significant advancement in targeted drug delivery, offering enhanced bioavailability, controlled release, and specific targeting capabilities. This review discusses the types of lipoidal vesicular systems, their methods of characterization, method development, applications, advantages, challenges, and future perspectives. These systems have shown immense potential in diverse therapeutic areas, including cancer therapy, infectious diseases, gene therapy, and transdermal drug delivery. Despite the challenges in stability, scalability, and targeting, ongoing research and technological advancements promise to expand their applications and improve therapeutic outcomes.
Keywords:
Lipoidal vesicular systems; Drug delivery; Liposomes; Ethosomes; Targeted delivery; Controlled release
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
